APO Research
Talk to an analyst

APO RESEARCH · REPORT

IL-17 Monoclonal Antibody Injections

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global IL-17 Monoclonal Antibody Injections Industry Growth and Trends Forecast to 2032

28 December 202571 pages

Choose your research edition.

Industry ResearchIL-17 Monoclonal Antibody Injections Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal IL-17 Monoclonal Antibody Injections Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal IL-17 Monoclonal Antibody Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IL-17 Monoclonal Antibody Injections Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal IL-17 Monoclonal Antibody Injections Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global IL-17 Monoclonal Antibody Injections market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for IL-17 Monoclonal Antibody Injections is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for IL-17 Monoclonal Antibody Injections is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IL-17 Monoclonal Antibody Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of IL-17 Monoclonal Antibody Injections include Novartis, Eli Lilly and Co., UCB and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global IL-17 Monoclonal Antibody Injections market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The IL-17 Monoclonal Antibody Injections market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global IL-17 Monoclonal Antibody Injections market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to IL-17 Monoclonal Antibody Injections.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global IL-17 Monoclonal Antibody Injections market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

IL-17 Monoclonal Antibody Injections Market by Company

Novartis

Eli Lilly and Co.

UCB

AstraZeneca

IL-17 Monoclonal Antibody Injections Segment by Type

Human Origin

Rat Origin

Other

IL-17 Monoclonal Antibody Injections Segment by Application

Hospital

Clinic

Other

IL-17 Monoclonal Antibody Injections Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IL-17 Monoclonal Antibody Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IL-17 Monoclonal Antibody Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IL-17 Monoclonal Antibody Injections.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of IL-17 Monoclonal Antibody Injections manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of IL-17 Monoclonal Antibody Injections in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Human Origin Table 2. Major Company of Rat Origin Table 3. Major Company of Other Table 4. Global IL-17 Monoclonal Antibody Injections Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units) Table 6. Global IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Type (2021-2026) Table 7. Global IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (US$ Million) Table 8. Global IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Type (2021-2026) Table 9. Global IL-17 Monoclonal Antibody Injections Price by Type (2021-2026) & (US$/Unit) Table 10. Global IL-17 Monoclonal Antibody Injections Sales by Type (2027-2032) & (K Units) Table 11. Global IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Type (2027-2032) Table 12. Global IL-17 Monoclonal Antibody Injections Sales by Type (2027-2032) & (US$ Million) Table 13. Global IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Type (2027-2032) Table 14. Global IL-17 Monoclonal Antibody Injections Price by Type (2027-2032) & (US$/Unit) Table 15. North America IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units) Table 16. North America IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (US$ Million) Table 17. Europe IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units) Table 18. Europe IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units) Table 22. Latin America IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (US$ Million) Table 25. IL-17 Monoclonal Antibody Injections Industry Trends Table 26. IL-17 Monoclonal Antibody Injections Industry Drivers Table 27. IL-17 Monoclonal Antibody Injections Industry Opportunities and Challenges Table 28. IL-17 Monoclonal Antibody Injections Industry Restraints Table 29. Global IL-17 Monoclonal Antibody Injections Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Company (2021-2026) Table 31. Global IL-17 Monoclonal Antibody Injections Sales by Company (2021-2026) & (K Units) Table 32. Global IL-17 Monoclonal Antibody Injections Sales Share by Company (2021-2026) Table 33. Global IL-17 Monoclonal Antibody Injections Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global IL-17 Monoclonal Antibody Injections Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global IL-17 Monoclonal Antibody Injections Major Company Production Sites and Headquarters Table 36. Global IL-17 Monoclonal Antibody Injections Company, Product Type & Application Table 37. Global IL-17 Monoclonal Antibody Injections Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global IL-17 Monoclonal Antibody Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global IL-17 Monoclonal Antibody Injections Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global IL-17 Monoclonal Antibody Injections Sales by Region (2021-2026) & (K Units) Table 42. Global IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Region (2021-2026) Table 43. Global IL-17 Monoclonal Antibody Injections Sales by Region (2021-2026) & (US$ Million) Table 44. Global IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Region (2021-2026) Table 45. Global IL-17 Monoclonal Antibody Injections Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global IL-17 Monoclonal Antibody Injections Sales by Region (2027-2032) & (K Units) Table 47. Global IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Region (2027-2032) Table 48. Global IL-17 Monoclonal Antibody Injections Sales by Region (2027-2032) & (US$ Million) Table 49. Global IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Region (2027-2032) Table 50. Global IL-17 Monoclonal Antibody Injections Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global IL-17 Monoclonal Antibody Injections Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units) Table 53. Global IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Application (2021-2026) Table 54. Global IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (US$ Million) Table 55. Global IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Application (2021-2026) Table 56. Global IL-17 Monoclonal Antibody Injections Price by Application (2021-2026) & (US$/Unit) Table 57. Global IL-17 Monoclonal Antibody Injections Sales by Application (2027-2032) & (K Units) Table 58. Global IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Application (2027-2032) Table 59. Global IL-17 Monoclonal Antibody Injections Sales by Application (2027-2032) & (US$ Million) Table 60. Global IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Application (2027-2032) Table 61. Global IL-17 Monoclonal Antibody Injections Price by Application (2027-2032) & (US$/Unit) Table 62. North America IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units) Table 63. North America IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (US$ Million) Table 64. Europe IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units) Table 65. Europe IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units) Table 69. Latin America IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (US$ Million) Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Novartis IL-17 Monoclonal Antibody Injections Product Portfolio Table 76. Novartis Recent Development Table 77. Eli Lilly and Co. Company Information Table 78. Eli Lilly and Co. Business Overview Table 79. Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Product Portfolio Table 81. Eli Lilly and Co. Recent Development Table 82. UCB Company Information Table 83. UCB Business Overview Table 84. UCB IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. UCB IL-17 Monoclonal Antibody Injections Product Portfolio Table 86. UCB Recent Development Table 87. AstraZeneca Company Information Table 88. AstraZeneca Business Overview Table 89. AstraZeneca IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. AstraZeneca IL-17 Monoclonal Antibody Injections Product Portfolio Table 91. AstraZeneca Recent Development Table 92. North America IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. North America IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units) Table 94. North America IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021-2026) Table 95. North America IL-17 Monoclonal Antibody Injections Sales Forecast by Country (2027-2032) & (K Units) Table 96. North America IL-17 Monoclonal Antibody Injections Sales Market Share Forecast by Country (2027-2032) Table 97. North America IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. North America IL-17 Monoclonal Antibody Injections Market Size by Country (2021-2026) & (US$ Million) Table 99. North America IL-17 Monoclonal Antibody Injections Market Share by Country (2021-2026) Table 100. North America IL-17 Monoclonal Antibody Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. North America IL-17 Monoclonal Antibody Injections Market Share Forecast by Country (2027-2032) Table 102. Europe IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Europe IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units) Table 104. Europe IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021-2026) Table 105. Europe IL-17 Monoclonal Antibody Injections Sales Forecast by Country (2027-2032) & (K Units) Table 106. Europe IL-17 Monoclonal Antibody Injections Sales Market Share Forecast by Country (2027-2032) Table 107. Europe IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Europe IL-17 Monoclonal Antibody Injections Market Size by Country (2021-2026) & (US$ Million) Table 109. Europe IL-17 Monoclonal Antibody Injections Market Share by Country (2021-2026) Table 110. Europe IL-17 Monoclonal Antibody Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Europe IL-17 Monoclonal Antibody Injections Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units) Table 114. Asia-Pacific IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021-2026) Table 115. Asia-Pacific IL-17 Monoclonal Antibody Injections Sales Forecast by Country (2027-2032) & (K Units) Table 116. Asia-Pacific IL-17 Monoclonal Antibody Injections Sales Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific IL-17 Monoclonal Antibody Injections Market Size by Country (2021-2026) & (US$ Million) Table 119. Asia-Pacific IL-17 Monoclonal Antibody Injections Market Share by Country (2021-2026) Table 120. Asia-Pacific IL-17 Monoclonal Antibody Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Asia-Pacific IL-17 Monoclonal Antibody Injections Market Share Forecast by Country (2027-2032) Table 122. Latin America IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Latin America IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units) Table 124. Latin America IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021-2026) Table 125. Latin America IL-17 Monoclonal Antibody Injections Sales Forecast by Country (2027-2032) & (K Units) Table 126. Latin America IL-17 Monoclonal Antibody Injections Sales Market Share Forecast by Country (2027-2032) Table 127. Latin America IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Latin America IL-17 Monoclonal Antibody Injections Market Size by Country (2021-2026) & (US$ Million) Table 129. Latin America IL-17 Monoclonal Antibody Injections Market Share by Country (2021-2026) Table 130. Latin America IL-17 Monoclonal Antibody Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Latin America IL-17 Monoclonal Antibody Injections Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021-2026) Table 135. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Forecast by Country (2027-2032) & (K Units) Table 136. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa IL-17 Monoclonal Antibody Injections Market Size by Country (2021-2026) & (US$ Million) Table 139. Middle East and Africa IL-17 Monoclonal Antibody Injections Market Share by Country (2021-2026) Table 140. Middle East and Africa IL-17 Monoclonal Antibody Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Middle East and Africa IL-17 Monoclonal Antibody Injections Market Share Forecast by Country (2027-2032) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. IL-17 Monoclonal Antibody Injections Distributors List Table 145. IL-17 Monoclonal Antibody Injections Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. IL-17 Monoclonal Antibody Injections Image Figure 2. Global IL-17 Monoclonal Antibody Injections Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IL-17 Monoclonal Antibody Injections Market Size (2021-2032) & (US$ Million) Figure 4. Global IL-17 Monoclonal Antibody Injections Sales (2021-2032) & (K Units) Figure 5. Human Origin Image Figure 6. Global Human Origin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Rat Origin Image Figure 8. Global Rat Origin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global IL-17 Monoclonal Antibody Injections Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global IL-17 Monoclonal Antibody Injections Market Share by Type 2025 VS 2032 Figure 13. North America IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Type in 2025 Figure 14. North America IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Type in 2025 Figure 15. Europe IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Type in 2025 Figure 16. Europe IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Type in 2025 Figure 19. Latin America IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Type in 2025 Figure 20. Latin America IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 IL-17 Monoclonal Antibody Injections Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global IL-17 Monoclonal Antibody Injections Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global IL-17 Monoclonal Antibody Injections Market Share by Application 2025 VS 2032 Figure 33. North America IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Application in 2025 Figure 34. North America IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Application in 2025 Figure 35. Europe IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Application in 2025 Figure 36. Europe IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Application in 2025 Figure 39. Latin America IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Application in 2025 Figure 40. Latin America IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Market Share in Value by Application in 2025 Figure 43. North America IL-17 Monoclonal Antibody Injections Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America IL-17 Monoclonal Antibody Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America IL-17 Monoclonal Antibody Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America IL-17 Monoclonal Antibody Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe IL-17 Monoclonal Antibody Injections Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe IL-17 Monoclonal Antibody Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe IL-17 Monoclonal Antibody Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe IL-17 Monoclonal Antibody Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific IL-17 Monoclonal Antibody Injections Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific IL-17 Monoclonal Antibody Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific IL-17 Monoclonal Antibody Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific IL-17 Monoclonal Antibody Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America IL-17 Monoclonal Antibody Injections Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America IL-17 Monoclonal Antibody Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America IL-17 Monoclonal Antibody Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America IL-17 Monoclonal Antibody Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa IL-17 Monoclonal Antibody Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa IL-17 Monoclonal Antibody Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. IL-17 Monoclonal Antibody Injections Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. IL-17 Monoclonal Antibody Injections Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Human Origin
  • Rat Origin
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Novartis
  • Eli Lilly and Co.
  • UCB
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global IL-17 Monoclonal Antibody Injections Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global IL-17 Monoclonal Antibody Injections Sales Estimates and Forecasts (2021-2032)
  5. 1.3 IL-17 Monoclonal Antibody Injections Market by Type
  6. 1.3.1 Human Origin
  7. 1.3.2 Rat Origin
  8. 1.3.3 Other
  9. 1.4 Global IL-17 Monoclonal Antibody Injections Market Size by Type
  10. 1.4.1 Global IL-17 Monoclonal Antibody Injections Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global IL-17 Monoclonal Antibody Injections Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global IL-17 Monoclonal Antibody Injections Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America IL-17 Monoclonal Antibody Injections Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe IL-17 Monoclonal Antibody Injections Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific IL-17 Monoclonal Antibody Injections Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America IL-17 Monoclonal Antibody Injections Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 IL-17 Monoclonal Antibody Injections Industry Trends
  2. 2.2 IL-17 Monoclonal Antibody Injections Industry Drivers
  3. 2.3 IL-17 Monoclonal Antibody Injections Industry Opportunities and Challenges
  4. 2.4 IL-17 Monoclonal Antibody Injections Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by IL-17 Monoclonal Antibody Injections Revenue (2021-2026)
  2. 3.2 Global Top Players by IL-17 Monoclonal Antibody Injections Sales (2021-2026)
  3. 3.3 Global Top Players by IL-17 Monoclonal Antibody Injections Price (2021-2026)
  4. 3.4 Global IL-17 Monoclonal Antibody Injections Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global IL-17 Monoclonal Antibody Injections Major Company Production Sites & Headquarters
  6. 3.6 Global IL-17 Monoclonal Antibody Injections Company, Product Type & Application
  7. 3.7 Global IL-17 Monoclonal Antibody Injections Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global IL-17 Monoclonal Antibody Injections Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 IL-17 Monoclonal Antibody Injections Players Market Share by Revenue in 2025
  11. 3.8.3 2025 IL-17 Monoclonal Antibody Injections Tier 1, Tier 2, and Tier 3
4 IL-17 Monoclonal Antibody Injections Regional Status and Outlook
  1. 4.1 Global IL-17 Monoclonal Antibody Injections Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global IL-17 Monoclonal Antibody Injections Historic Market Size by Region
  3. 4.2.1 Global IL-17 Monoclonal Antibody Injections Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global IL-17 Monoclonal Antibody Injections Sales in Value by Region (2021-2026)
  5. 4.2.3 Global IL-17 Monoclonal Antibody Injections Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global IL-17 Monoclonal Antibody Injections Forecasted Market Size by Region
  7. 4.3.1 Global IL-17 Monoclonal Antibody Injections Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global IL-17 Monoclonal Antibody Injections Sales in Value by Region (2027-2032)
  9. 4.3.3 Global IL-17 Monoclonal Antibody Injections Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 IL-17 Monoclonal Antibody Injections by Application
  1. 5.1 IL-17 Monoclonal Antibody Injections Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global IL-17 Monoclonal Antibody Injections Market Size by Application
  6. 5.2.1 Global IL-17 Monoclonal Antibody Injections Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global IL-17 Monoclonal Antibody Injections Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global IL-17 Monoclonal Antibody Injections Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America IL-17 Monoclonal Antibody Injections Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe IL-17 Monoclonal Antibody Injections Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific IL-17 Monoclonal Antibody Injections Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America IL-17 Monoclonal Antibody Injections Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis IL-17 Monoclonal Antibody Injections Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis IL-17 Monoclonal Antibody Injections Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Eli Lilly and Co.
  8. 6.2.1 Eli Lilly and Co. Company Information
  9. 6.2.2 Eli Lilly and Co. Business Overview
  10. 6.2.3 Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Product Portfolio
  12. 6.2.5 Eli Lilly and Co. Recent Developments
  13. 6.3 UCB
  14. 6.3.1 UCB Company Information
  15. 6.3.2 UCB Business Overview
  16. 6.3.3 UCB IL-17 Monoclonal Antibody Injections Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 UCB IL-17 Monoclonal Antibody Injections Product Portfolio
  18. 6.3.5 UCB Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca IL-17 Monoclonal Antibody Injections Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca IL-17 Monoclonal Antibody Injections Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
7 North America by Country
  1. 7.1 North America IL-17 Monoclonal Antibody Injections Sales by Country
  2. 7.1.1 North America IL-17 Monoclonal Antibody Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026)
  4. 7.1.3 North America IL-17 Monoclonal Antibody Injections Sales Forecast by Country (2027-2032)
  5. 7.2 North America IL-17 Monoclonal Antibody Injections Market Size by Country
  6. 7.2.1 North America IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America IL-17 Monoclonal Antibody Injections Market Size by Country (2021-2026)
  8. 7.2.3 North America IL-17 Monoclonal Antibody Injections Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe IL-17 Monoclonal Antibody Injections Sales by Country
  2. 8.1.1 Europe IL-17 Monoclonal Antibody Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026)
  4. 8.1.3 Europe IL-17 Monoclonal Antibody Injections Sales Forecast by Country (2027-2032)
  5. 8.2 Europe IL-17 Monoclonal Antibody Injections Market Size by Country
  6. 8.2.1 Europe IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe IL-17 Monoclonal Antibody Injections Market Size by Country (2021-2026)
  8. 8.2.3 Europe IL-17 Monoclonal Antibody Injections Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific IL-17 Monoclonal Antibody Injections Sales by Country
  2. 9.1.1 Asia-Pacific IL-17 Monoclonal Antibody Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific IL-17 Monoclonal Antibody Injections Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific IL-17 Monoclonal Antibody Injections Market Size by Country
  6. 9.2.1 Asia-Pacific IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific IL-17 Monoclonal Antibody Injections Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific IL-17 Monoclonal Antibody Injections Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America IL-17 Monoclonal Antibody Injections Sales by Country
  2. 10.1.1 South America IL-17 Monoclonal Antibody Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026)
  4. 10.1.3 South America IL-17 Monoclonal Antibody Injections Sales Forecast by Country (2027-2032)
  5. 10.2 South America IL-17 Monoclonal Antibody Injections Market Size by Country
  6. 10.2.1 South America IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America IL-17 Monoclonal Antibody Injections Market Size by Country (2021-2026)
  8. 10.2.3 South America IL-17 Monoclonal Antibody Injections Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Country
  2. 11.1.1 Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa IL-17 Monoclonal Antibody Injections Market Size by Country
  6. 11.2.1 Middle East and Africa IL-17 Monoclonal Antibody Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa IL-17 Monoclonal Antibody Injections Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa IL-17 Monoclonal Antibody Injections Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 IL-17 Monoclonal Antibody Injections Value Chain Analysis
  2. 12.1.1 IL-17 Monoclonal Antibody Injections Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 IL-17 Monoclonal Antibody Injections Production Mode & Process
  7. 12.2 IL-17 Monoclonal Antibody Injections Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 IL-17 Monoclonal Antibody Injections Distributors
  10. 12.2.3 IL-17 Monoclonal Antibody Injections Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst